Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A165a, VEGF-A165b, PIGF and VE-cadherin
Open Access
- 23 November 2017
- journal article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 131 (23), 2763-2775
- https://doi.org/10.1042/cs20171252
Abstract
The human placenta nourishes and protects the developing foetus whilst influencing maternal physiology for fetal advantage. It expresses several members of the vascular endothelial growth factor (VEGF) family including the pro-angiogenic/pro-permeability VEGF-A165a isoform, the anti-angiogenic VEGF-A165b, placental growth factor (PIGF) and their receptors, VEGFR1 and VEGFR2. Alterations in the ratio of these factors during gestation and in complicated pregnancies have been reported; however, the impact of this on feto-placental endothelial barrier integrity is unknown. The present study investigated the interplay of these factors on junctional occupancy of VE-cadherin and macromolecular leakage in human endothelial monolayers and the perfused placental microvascular bed. Whilst VEGF-A165a (50 ng/ml) increased endothelial monolayer albumin permeability (P0.05) or PlGF (P>0.05) did not. Moreover, VEGF-A165b (100 ng/ml; P0.05) inhibited VEGF-A165a-induced permeability when added singly. PlGF abolished the VEGF-A165b-induced reduction in VEGF-A165a-mediated permeability (P>0.05); PlGF was found to compete with VEGF-A165b for binding to Flt-1 at equimolar affinity. Junctional occupancy of VE-cadherin matched alterations in permeability. In the perfused microvascular bed, VEGF-A165b did not induce microvascular leakage but inhibited and reversed VEGF-A165a-induced loss of junctional VE-cadherin and tracer leakage. These results indicate that the anti-angiogenic VEGF-A165b isoform does not increase permeability in human placental microvessels or HUVEC primary cells and can interrupt VEGF-A165a-induced permeability. Moreover, the interplay of these isoforms with PIGF (and s-flt1) suggests that the ratio of these three factors may be important in determining the placental and endothelial barrier in normal and complicated pregnancies.Keywords
This publication has 39 references indexed in Scilit:
- New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formationAngiogenesis, 2012
- Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal outputBlood, 2011
- Placenta Growth Factor-1 Exerts Time-Dependent Stabilization of Adherens Junctions Following VEGF-Induced Vascular PermeabilityPLOS ONE, 2011
- Recombinant Human VEGF165b Inhibits Experimental Choroidal NeovascularizationInvestigative Ophthalmology & Visual Science, 2010
- VEGF-A165b Is Cytoprotective and Antiangiogenic in the RetinaInvestigative Ophthalmology & Visual Science, 2010
- The role of adherens junctions and VE-cadherin in the control of vascular permeabilityJournal of Cell Science, 2008
- Vascular Endothelial Growth Factor (VEGF)-A165b Is a Weak In vitro Agonist for VEGF Receptor-2 Due to Lack of Coreceptor Binding and Deficient Regulation of Kinase ActivityCancer Research, 2008
- Neuropilin-1 Regulates Vascular Endothelial Growth Factor–Mediated Endothelial PermeabilityCirculation Research, 2005
- VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice VariantCancer Research, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaThe New England Journal of Medicine, 2004